1. Li, Meiyu, Li, Xiaofei, Chen, Shujia, Sun, Guoyan, Guo, Lianyi. 2022. IPO5 Mediates EMT and Promotes Esophageal Cancer Development through the RAS-ERK Pathway. In Oxidative medicine and cellular longevity, 2022, 6570879. doi:10.1155/2022/6570879. https://pubmed.ncbi.nlm.nih.gov/36120598/
2. Wang, Zhen-Qi, Liu, Yang, Wu, Ning, Zhang, Xuan, Wu, Jiang. 2010. Genetic and functional study of the IPO5 gene in schizophrenia. In Psychiatry research, 187, 460-1. doi:10.1016/j.psychres.2010.05.010. https://pubmed.ncbi.nlm.nih.gov/20542336/
3. Li, X-F, Aierken, A-L-D, Shen, L. . IPO5 promotes malignant progression of esophageal cancer through activating MMP7. In European review for medical and pharmacological sciences, 24, 4246-4254. doi:10.26355/eurrev_202004_21004. https://pubmed.ncbi.nlm.nih.gov/32373960/
4. Mihalas, Bettina P, Western, Patrick S, Loveland, Kate L, McLaughlin, Eileen A, Holt, Janet E. 2015. Changing expression and subcellular distribution of karyopherins during murine oogenesis. In Reproduction (Cambridge, England), 150, 485-96. doi:10.1530/REP-14-0585. https://pubmed.ncbi.nlm.nih.gov/26399853/
5. Li, Dan, Fu, Shaozu, Wu, Zhengqian, Liu, Xiangtao, Zheng, Haixue. 2019. DDX56 inhibits type I interferon by disrupting assembly of IRF3-IPO5 to inhibit IRF3 nucleus import. In Journal of cell science, 133, . doi:10.1242/jcs.230409. https://pubmed.ncbi.nlm.nih.gov/31340999/